China Universal Asset Management Company’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $844K | Buy |
|
|||||
|
2025
Q1 | $585K | Sell |
|
|||||
|
2024
Q4 | $712K | Buy |
|
|||||
|
2024
Q3 | $770K | Buy |
|
|||||
|
2024
Q2 | $539K | Sell |
|
|||||
|
2024
Q1 | $1.05M | Buy |
|
|||||
|
2023
Q4 | $575K | Buy |
|
|||||
|
2023
Q3 | $92.6K | Buy |
|
|||||
|
2023
Q2 | $58K | Sell |
|
|||||
|
2023
Q1 | $48.2K | Sell |
|
|||||
|
2022
Q4 | $146K | Sell |
|
|||||
|
2022
Q3 | $1.61M | Buy |
|
|||||
|
2022
Q2 | $81K | Hold |
|
|||||
|
2022
Q1 | $84K | Buy |
|